Trial Profile
Predicting Medication Response in Obsessive Compulsive Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Clomipramine (Primary) ; Duloxetine (Primary) ; Escitalopram (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 01 Aug 2011 New trial record